ELECT 24 Top Ad

Analyst Update: Foamix Pharmaceuticals Ltd, Jazz Pharmaceuticals plc, and Healthways, Inc.

Analysts revised their ratings and price targets on Foamix Pharmaceuticals Ltd (FOMX), Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ), and Healthways, Inc. (HWAY)

Aug 10, 2016 at 3:52 PM
facebook X logo linkedin


Analysts are weighing in on biopharmaceutical stocks Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) and Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), as well as health management stock Healthways, Inc. (NASDAQ:HWAY). Here's a quick roundup of today's brokerage notes on FOMX, JAZZ, and HWAY.

  • FOMX was down more than 7% at its intraday low, after reporting a larger-than-expected per-share loss for the second quarter. However, the stock has since clawed to a 0.5% gain to sit at $8.18, and some analysts expect much more upside for FOMX. Specifically, Guggenheim raised its price target on FOMX to $20 from $10 -- in territory not charted -- and reiterated a "buy" endorsement. Since its most recent low at $5.70 in June, Foamix Pharmaceuticals Ltd shares have added nearly 44%, with pullbacks contained by its 20-day moving average. Short sellers have been keeping a close eye on FOMX, with short interest up 1.5% over the previous two reporting periods, now accounting for 8.8% of FOMX's float -- which would take almost two weeks of trading to cover, at FOMX's average daily volume. 
  • JAZZ is down 6.8% at $139.80 -- set for its worst session in five months -- after an earnings miss and and downwardly revised full-year forecast, though it's just one of several healthcare stocks swimming in red ink today. A handful of analysts have since issued price-target adjustments for JAZZ, including bumps from BMO and Leerink, to $193 and $202, respectively, as well as cuts from Mizuho and Goldman Sachs, to $185 and $195, respectively. Jazz Pharmaceuticals plc – Ordinary Shares is down 22.8% year-over-year, with the shares running into resistance in the $155-$160 region -- home to their 80-week moving average -- since April. Nevertheless, analysts are still upbeat on the stock, with all 11 brokerage firms weighing in calling JAZZ a "strong buy."
  • HWAY is up 18.8% at $21.45 -- and just off a new annual high of $22.76 -- after the company reported an earnings beat and announced that Robert E. Dries will take over the position of chief financial officer. Additionally, HWAY received price-target raises from Piper Jaffray (to $25.50), UBS (to $19), and Barrington (to $29). Thanks to today's pop, the stock is now up 67% year-to-date, and there's likely some bearish traders kicking rocks. Short interest on Healthways, Inc. jumped 5.2% in the latest reporting period, and now accounts for 9.3% of the stock's available float 
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check
 

Biden’s government just announced a new government "stimulus program"...

And it could hand you a payment for as much as $7,882 — each quarter.

See, it has to do with a recent 19-page memo from Biden’s office...

Directing the government to once again send a form of "stimulus payments" to the mailboxes of Americans during these difficult times.

Better still, you can collect these payouts every single quarter — for life...

Payments run as high as $7,882... And it only takes five minutes to sign up.

I call this the "Stimulus Stipends" program…

And Forbes recently declared that you can "retire rich" thanks to this program.

So if you want to start cashing in your quarterly payouts — courtesy of the U.S government...

Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here. 
 (ad)
 

election 2024 report

                                                  AD                                                  
best AI trade you can make today…?
(it’s not MSFT, GOOGL, AMZN or AAPL)

                                                  AD                                                  

 
 

VOLATILITY SCORECARD

 


                                               AD                                                    
Crazy Opportunity!! Tiny AI Stock just $3
“This Type of AI Will Be Worth “Ten MSFTs.”

                                               AD                                                    

 
4 AI STOCKS TO BUY NOW
 

                                                  AD                                                  
best AI trade you can make today…?
(it’s not MSFT, GOOGL, AMZN or AAPL)

                                                  AD